Cuprajake why would people then buy the likes of say the lr24? Surely the only advantage it then has is adjustable pre infusion.
From my perspective, providing it delivers within acceptable parameters:
- form factor (a lot smaller);
- Price (£1k rather than £3.5k);
I don’t think it will kill the existing range, but it would rather complement the range if done right. For me, the main concerns as an end user are the the brand new group and it’s operational capabilities (temperature range, stability, monitoring, pressure range, etc). Hopefully all of those will be demonstrated at some point, openly. And, if it delivers, I’ll seriously consider it. Unless ACS comes up with their own… 😊